Private Equity

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

The CEO of Genenta Science now owns 10% of the company, all bought on the open market. What does this bold insider move signal for its cancer therapy?

Nova Minerals is raising $20M to advance its Estelle Project, a key Alaskan site for gold and the strategically vital mineral antimony amid global supply woes.

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

A publicly listed venture builder reports explosive growth and a radical new strategy: using a video game to democratize venture capital for everyone.

Denarius Metals solidifies its Zancudo gold-silver project in Colombia by filing a key technical report, validating a major resource update.

In a major move for the AI infrastructure race, TeraWulf and Fluidstack secure massive project financing for a 168 MW Texas facility, backed by Google.

Following PwC's resignation, the private credit firm's move to MNP signals a new chapter in its financial governance as it streamlines operations.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

Titan Mining's new funding aims to end a 70-year U.S. graphite production gap, a critical move for the nation's EV and energy independence goals.

As Applied Digital preps its Q2 results, investors watch to see if its multi-billion dollar contracts can quell market volatility and affirm its AI future.

Avocado giant Mission Produce sets a new course, naming a successor to its founder CEO and refreshing its board to navigate future global market demands.

Altus Power acquires over 100 solar and storage sites from Greenbacker, boosting its capacity to 1.3 GW and signaling a new phase of consolidation.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

Trinity Investments expands its European empire, acquiring The Hoxton, Poblenou in a move that highlights its multi-segment strategy in top-tier markets.

Millions struggle to swallow pills. Azurity's new FDA-approved liquid hypertension drug, Javadin, offers a ready-to-use solution for better adherence.

A new report reveals a shocking decline in Canadian public companies and IPOs, signaling economic stagnation and shutting out average investors.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.